Poised To Produce A/H1N1 Vaccine, Sanofi Pasteur Ramping Up Capacity In U.S., Developing Defense For Another Killer Virus
This article was originally published in PharmAsia News
Executive Summary
BEIJING - On standby to rapidly turn out a vaccine for A/H1N1 if the World Health Organization declares a continents-wide pandemic is emerging, scientists at Sanofi Pasteur are also working with the UN group to develop a defense for the tropical dengue virus, which has already killed far more people worldwide than the swine flu